MY ACCOUNT | NEWSLETTER |

Cats with feline leukemia virus respond worse to dental extractions

A study underlines the importance of recognizing the effect of FeLV status on the prognosis of feline patients who have to undergo this type of action.


A research team has conducted a study that aims to evaluate and compare the clinical outcome after dental extractions of cats with FCGS infected with feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV).

A retrospective case series including cats with a diagnosis of FCGS, availability of detailed clinical records, full-mouth dental radiographs, and retroviral disease test results were evaluated. Similarly, the effectiveness of surgical treatment was recorded. For the investigation, 111 cats were included in three groups (control, FIV and FeLV): 60 in the control group, 29 cats positive for FIV and 22 for FeLV.

Compared with control cases, FeLV-positive cats had significantly fewer proliferative stomatitis lesions and tended to have more tongue ulcers. At the same time, FeLV-positive cats had significantly fewer dental resorption lesions. No other significant differences in clinical signs of FCGS were found between groups.

FeLV-positive cats had a significantly worse outcome after dental extractions compared to the other groups. In fact, FeLV-positive cats were 7.5 times more likely to not improve after dental extractions.

This study concludes that the response to dental extractions in FeLV-positive cats is significantly worse compared to cats that do not carry the retroviral disease. Therefore, it is important to recognize the effect of FeLV status on the prognosis of these cats.

A Case Series Analysis of Dental Extractions' Outcome in Cats with Chronic Gingivostomatitis Carrying Retroviral Disease” Marta Silva, et al. Animals (Basel). 2021 Nov 19;11(11):3306. doi: 10.3390/ani11113306

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Nonhypotensive autonomic agents in veterinary ophthalmology

Like0
Dislike0

Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology

Like0
Dislike0

Probiotics and its potential role in poultry production: A review

Like0
Dislike0

Joyful send-off for legendary biomedical sciences professor

Like0
Dislike0

Rescue therapy with doxorubicin-based chemotherapy for relapsing or refractory feline lymphoma: a retrospective study of 23 cases

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top